Astrana Health Inc. - Common Stock (ASTH)

35.85
+1.72 (5.03%)
NASDAQ· Last Trade: Aug 7th, 1:53 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook
Healthcare services company Astrana Health missed Wall Street’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million. Next ...
Via StockStory · August 7, 2026
Astrana Health Q2 Earnings Call Highlightsmarketbeat.com
Astrana Health (NASDAQ:ASTH) reported second-quarter 2026 revenue of $973 million, up 49% from a year earlier, while adjusted EBITDA increased 43% to $69 million. Adjusted diluted earnings per share reached a record $0.80, up 45% year over year, as the company cited growth in value-based care arrang
Via MarketBeat · August 6, 2026
Astrana Health (NASDAQ:ASTH) Falls on Q2 Revenue Miss Despite Earnings Beatchartmill.com
Via Chartmill · August 6, 2026
Astrana Health (NASDAQ:ASTH) Beats Q2 CY2026 Non-GAAP EPS Estimates, Stock Soars 5.1%
Healthcare services company Astrana Health fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million....
Via StockStory · August 6, 2026
Astrana Health (NASDAQ:ASTH) Screens as a Powerful Minervini Trend Template Stock with High Growth Momentumchartmill.com
Via Chartmill · July 3, 2026
Astrana Health (NASDAQ:ASTH) Post-Earnings Slide: Revenue Beat Fails to Offset EPS Misschartmill.com
Via Chartmill · May 7, 2026
Astrana Health (ASTH) Q2 Earnings: What To Expect
Healthcare services company Astrana Health will be reporting results this Thursday after market hours. Here’s what to look for. Astrana Health beat analysts’...
Via StockStory · August 4, 2026
2 Reasons to Like ASTH and 1 to Stay Skeptical
The past six months have been a windfall for Astrana Health’s shareholders. The company’s stock price has jumped 79%, hitting $49.01 per share. This was part...
Via StockStory · July 15, 2026
1 Profitable Stock to Target This Week and 2 We Question
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · July 10, 2026
2 Healthcare Stocks for Long-Term Investors and 1 We Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
Via StockStory · June 30, 2026
2 Russell 2000 Stocks with Exciting Potential and 1 We Ignore
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Via StockStory · June 15, 2026
2 Growth Stocks Set to Flourish and 1 Facing Headwinds
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...
Via StockStory · June 5, 2026
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...
Via StockStory · May 25, 2026
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...
Via StockStory · May 21, 2026
1 Cash-Producing Stock to Consider Right Now and 2 We Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via StockStory · May 19, 2026
2 Mooning Stocks Worth Investigating and 1 We Question
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos...
Via StockStory · May 15, 2026
5 Revealing Analyst Questions From Astrana Health’s Q1 Earnings Call
Astrana Health’s first quarter was marked by progress in platform integration and the expansion of its AI-driven care model, leading to strong revenue growth...
Via StockStory · May 14, 2026
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectationsmarketbeat.com
Astrana Health (NASDAQ:ASTH) CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected first-quarter trends across medical costs, free cash flow and revenue. Speaking at a Bank of America healthc
Via MarketBeat · May 12, 2026
1 Unpopular Stock That Deserves a Second Chance and 2 That Underwhelm
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...
Via StockStory · May 11, 2026
Astrana Health (ASTH) Q1 2026 Earnings Transcriptfool.com
Astrana Health (ASTH) Q1 2026 Earnings Transcript
Via The Motley Fool · May 8, 2026
ASTH Q1 Deep Dive: AI-Enabled Platform, Full-Risk Expansion, and Operating Leverage Shape Results
Healthcare services company Astrana Health reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 55.6% year on year to $965.1 mill...
Via StockStory · May 8, 2026
Astrana Health (NASDAQ:ASTH) Beats Q1 CY2026 Sales Expectations
Healthcare services company Astrana Health reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 55.6% year on year to $965.1 m...
Via StockStory · May 7, 2026
Astrana Health (ASTH) Q1 Earnings Report Preview: What To Look For
Healthcare services company Astrana Health will be reporting results this Thursday afternoon. Here’s what to look for. Astrana Health beat analysts’ revenue ...
Via StockStory · May 5, 2026
2 Profitable Stocks on Our Watchlist and 1 Facing Headwinds
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Via StockStory · May 4, 2026
1 Healthcare Stock to Target This Week and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-...
Via StockStory · April 22, 2026